OSAM
ANIP icon

O'Shaughnessy Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History

O'Shaughnessy Asset Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,142
Closed -$200K – 2117
2024
Q2 		$200K Sell
3,142
-15
-0.5% -$974 ﹤0.01% 1542
2024
Q1 		$218K Buy
+3,157
New +$191K ﹤0.01% 1471
2020
Q3 		– Sell
-3,297
Closed -$107K – 1862
2020
Q2 		$107K Sell
3,297
-9,528
-74% -$342K ﹤0.01% 823
2020
Q1 		$525K Sell
12,825
-4,471
-26% -$238K 0.02% 289
2019
Q4 		$1.06M Sell
17,296
-2,689
-13% -$178K 0.02% 263
2019
Q3 		$1.46M Buy
19,985
+5,157
+35% +$386K 0.03% 216
2019
Q2 		$1.22M Buy
+14,828
New +$1.05M 0.03% 239

Other funds holding ANIP

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $34.9B AUM 18.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return